Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 December 2022 | Story Jóhann Thormählen | Photo Supplied
Kopano Melesi
Kopano Melesi has been involved with teams such as the USSA U21, South African U20 and U23 sides, and works at the Mahd Sports Academy in Saudi Arabia.

They were ambitious students, in the same study group, and graduated together at the UFS. Only a few years later, three friends from the class of 2015 are in charge of the strength and conditioning of three top sports teams in South Africa.

The former classmates Bongani Tim Qumbu (Springboks), Kopano Melesi (Bafana Bafana), and Tumi Masekela (Proteas men’s cricket) are making sure the best in the country is in shape to compete internationally.

And the trio are not the only sport scientists from their class to excel. Others like Obakeng Molopyane, who did Wayde van Niekerk’s conditioning, are also part of this special group. It all started while doing their honours in Human Movement Science and being mentored by some of the best in the business, like Prof Derik Coetzee, who was the conditioning coach when the Boks won the 2007 World Cup.

Melesi says Prof Coetzee played a big role in their development as they had a good road map to follow. “He exposed us to things in the professional world that a normal student could only dream of. We worked with national teams, domestic and international professional teams.”

“When we went out there, we were not unsure about our abilities and capabilities to execute.” According to Masekela, they were keen students and had great UFS lecturers.

“We would meet up most afternoons after lectures to break down the lesson that we had until we understood exactly what the lesson was about.”

“This included digging into the history of how certain theories came about, then debating on our own thoughts on the topic,” he says.

All three gained experience while still studying. Qumbu worked with the Kovsie Young Guns and Irawas, Melesi with the Kovsie soccer team, and Masekela with the UFS cricket team.

Melesi says early exposure, through ‘volunteering’ at local teams, is key if you want to reach the top.

“I would advise aspiring students to engage with their lecturers as much as possible in class, as they have a lot of practical knowledge about sport science that you will not read in a book,” says Masekela.

 

 


 

Kopano Melesi Tumi Masekela Bongani Tim Qumbu

Kopano Melesi has been involved with teams such as the USSA U21, South African U20 and U23 sides, and works at the Mahd Sports Academy in Saudi Arabia.

 

Tumi Masekela played cricket for the University of the Free State, Northerns, the Knights and Titans. He is now the strength and conditioning coach of the Proteas.

 

Bongani Tim Qumbu (left) worked his way to the top. He now looks after some of the best rugby players in SA like the Springbok captain Siya Kolisi. Here they are at a Bok training session.

Photo: Supplied Photo: Cricket South Africa Photo: Supplied

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept